Topicals represent 5.1% of total prescriptions and 14% of total drug cost, and are being prescribed as an alternative to some oral medications. Within this class, cost drivers including prescription (Rx) and private label topical analgesics (PLTAs) are associated with limited clinical efficacy and exorbitant pricing that often eliminates them as a favorable first-line therapy option. These and other challenges call for careful oversight that includes identification, clinical review and intervention, and/or recommendation of therapeutic alternatives where appropriate to help control inappropriate utilization and spend. Watch the video blog to learn more.
More stories
Mitchell
News Release
Battery Electric Vehicle Collision Claims Continue to Rise Despite Sales Slowdown
Claims frequency for repairable battery electric vehicles has jumped 45% in the U.S.
Mitchell
Article
Plugged-In: EV Collision Insights Q2 2024
Do
Workers' Comp
Article
Specialty Solutions Spotlight: Common Work-From-Home Injuries
What are the most common work-from-home injuries and how are they treated? In today’s remote and hybrid work environments, accidents are
Register Now
CE Webinar
Navigating Home Health Services
On-Demand
In this webinar, we will educate adjusters and claims professionals on the various types of services provided in-home, the benefits of home health
Register Now
CE Webinar
Ethics – How Personal Perspectives Can Shape Ethical Decisions
On-Demand
This session will help attendees build a foundation for positive and consistent ethical decision making and how to assess self-performance.
WorkCompWire
Article